420 with CNW – How DOT Substance Testing Could Be Impacted by Marijuana Rescheduling

A commercial driver who uses cannabis under a state medical program may still face a verified positive drug test under federal transportation rules, even if the substance was obtained legally within that state. 

The issue has become more significant as federal officials begin changing cannabis’ classification under the CSA. The Transport Department has made clear that a shift toward Schedule 3 does not, by itself, permit marijuana use by workers in safety-sensitive transport roles. 

Last December, President Donald Trump directed the Justice Department to accelerate proceedings that could shift cannabis to Schedule 3. DOT said at the time that its testing requirements remained unchanged. 

In April, the DEA placed certain FDA-approved marijuana products and marijuana covered by state medical programs in Schedule 3. Meanwhile, a broader proceeding concerning marijuana’s overall federal classification continued, with hearings held during late June and July. 

Controlled substances placed in Schedule 3 remain subject to federal restrictions. A change in scheduling doesn’t automatically make state-approved medical cannabis permissible under federal rules or eliminate workplace drug-testing requirements. 

DOT oversees drug-testing requirements affecting millions of workers in aviation, trucking, rail, pipelines, transit, and other transportation sectors. The department has pointed to federal legislation enacted in 1991 as authority for testing controlled substances that present transportation safety concerns when used. 

The technical framework presents additional questions. DOT testing operates alongside federal workplace testing guidelines administered by the DHHS and laboratories certified under those requirements. Marijuana remains part of the federal testing panel, although some parts of the framework refer specifically to substances in Schedules 1 and 2. DOT and HHS have been examining how broader rescheduling could affect those requirements. 

For medical-review officers, the current position is clearer. A worker cannot generally overturn a confirmed cannabis result simply by producing their state medical-cannabis card, doctor’s recommendation, or dispensary documentation. DOT guidelines say such state authorization does not constitute a federally recognized prescription under the CSA. 

That means a driver who legally purchased cannabis through a licensed state dispensary could still have a positive DOT result verified rather than dismissed. 

Commercial drivers also face separate requirements administered by the FMCSA. Existing FMCSA guidelines have treated marijuana use as incompatible with federal qualification standards, although that guidance was developed when cannabis remained in Schedule 1. 

Federal regulations distinguish Schedule 1 substances from certain drugs in Schedules 2 through 5, creating a question about how the rules will apply if marijuana is ultimately classified more broadly in Schedule 3. FMCSA may therefore need to clarify how its medical-qualification standards interact with the changing federal schedule. 

For now, employers should continue following existing DOT testing requirements. State legalization does not override federal transportation rules, and the April DEA action does not establish that commercial drivers may use medical cannabis. 

Transportation companies should monitor developments from DEA, DOT, HHS, and FMCSA rather than relying solely on changes to cannabis’ federal classification. The scheduling process may alter federal policy, but it does not by itself determine what cannabis use means for employees operating within safety-sensitive transport roles. 

For now, cannabis industry operators like Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) will continue monitoring the federal drug regulatory landscape as it evolves in terms of what is or isn’t permitted for employees. 

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Archives

Select A Month
  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • September 2016
  • August 2016
  • July 2016
  • Official NewsWire Relationships

    Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

    CannabisNewsWire Currently Accepts

    Bitcoin

    Bitcoin

    Bitcoin Cash

    Bitcoin Cash

    Doge Coin

    Dogecoin

    Ethereum

    Ethereum

    Litecoin

    Litecoin

    USD Coin

    USD Coin

    Contact us: 512.354.7000